Bundibugyo Ebola outbreak: A harsh reminder of the need for broad vaccine strategies (bioworld.com)

• Bundibugyo outbreak highlights lack of specific vaccines or treatments.
• Multivalent vaccine platforms are urgently needed.
• Ongoing research aims to develop pan-filovirus vaccines.

"The Bundibugyo Ebola outbreak in Uganda exposes a critical gap: no approved vaccines or therapeutics exist for this species, unlike for Zaire and Sudan strains. The article underscores the urgency of developing multivalent vaccine platforms that can protect against multiple Ebola species, and highlights ongoing research and funding efforts to accelerate such platforms."